These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 19810172

  • 1. An evaluation of the activity of cephalosporins against Pseudomonas aeruginosa.
    Bauernfeind A.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():111-7. PubMed ID: 19810172
    [Abstract] [Full Text] [Related]

  • 2. In-vitro activity of ceftazidime against Pseudomonas aeruginosa: and its stability to pseudomonal beta-lactamases.
    Livermore DM, Williams RJ, Williams JD.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():163-7. PubMed ID: 19802980
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of rifampicin on the in-vitro activity of cefpirome or ceftazidime in combination with aminoglycosides against Pseudomonas aeruginosa.
    Valdes JM, Baltch AL, Smith RP, Hammer MC, Ritz WJ.
    J Antimicrob Chemother; 1990 Apr; 25(4):575-84. PubMed ID: 2112539
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ceftazidime: comparative in-vitro study.
    Verbist L, Verhaegen J.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():67-71. PubMed ID: 19802971
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hydrolysis of cefazolin by enzymes produced by Pseudomonas aeruginosa after exposure to ceftazidime in vitro.
    Papaioannidou P, Nitsas V, Mirtsou-Fidani V.
    Vojnosanit Pregl; 2009 Oct; 66(10):785-90. PubMed ID: 19938755
    [Abstract] [Full Text] [Related]

  • 14. The activity of ceftazidime, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.
    Rolston KV, Chandrasekar PH, LeFrock JL, Schell RF.
    Chemotherapy; 1984 Oct; 30(1):31-4. PubMed ID: 6420119
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of ceftazidime and other beta-lactam antibiotics against nosocomial strains of Pseudomonas aeruginosa.
    Santos Ferreira MO, Bacelar MJ, Canica MM.
    J Int Med Res; 1984 Oct; 12(6):356-60. PubMed ID: 6440822
    [Abstract] [Full Text] [Related]

  • 16. Comparison of cefpiramide (HR-810) and four anti-pseudomonal beta-lactam agents against pseudomonas isolates from children with cystic fibrosis.
    Aronoff SC, Klinger JD.
    J Antimicrob Chemother; 1985 May; 15(5):545-9. PubMed ID: 3924879
    [Abstract] [Full Text] [Related]

  • 17. Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model.
    den Hollander JG, Horrevorts AM, van Goor ML, Verbrugh HA, Mouton JW.
    Antimicrob Agents Chemother; 1997 Jan; 41(1):95-100. PubMed ID: 8980762
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa.
    Watanabe N, Hiruma R, Katsu K.
    J Antimicrob Chemother; 1992 Nov; 30(5):633-41. PubMed ID: 1493980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.